A Dose-Escalation Study of RO7875913 in Healthy Participants

NCT07342114 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: RO7875913
DRUG: Placebo

Sponsor

Genentech, Inc.